Influenza A

Influenza A virus is a member of the Orthomyxoviridae family and is responsible for seasonal flu outbreaks in humans. The virus has a segmented RNA genome, allowing for frequent genetic reassortment, which contributes to the phenomenon of antigenic variation. Antigenic variation involves changes in the viral surface proteins, hemagglutinin (HA) and neuraminidase (NA), leading to the classification of influenza A viruses into subtypes based on these proteins. Currently, there are 18 HA subtypes and 11 NA subtypes, resulting in a diverse pool of influenza A viruses circulating in animal reservoirs, particularly birds and swine. Seasonal influenza outbreaks occur annually, with the virus causing respiratory infections characterized by symptoms such as fever, cough, and body aches. The ability of influenza A to undergo antigenic drift, subtle changes in the viral surface proteins over time, necessitates the regular updating of influenza vaccines to match the circulating strains. This dynamic process of antigenic variation contributes to the challenges in predicting and preventing influenza outbreaks. Public health measures, including vaccination, antiviral medications, and hygiene practices, play a crucial role in mitigating the impact of seasonal influenza A outbreaks. Global surveillance efforts, such as those led by the World Health Organization (WHO), monitor circulating influenza strains to inform vaccine composition and guide public health responses to emerging threats, such as potential pandemics.